Role of extracellular vesicles in the high-fat diet-induced risk of Alzheimer disease
细胞外囊泡在高脂肪饮食诱发的阿尔茨海默病风险中的作用
基本信息
- 批准号:9385535
- 负责人:
- 金额:$ 19.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:ABCC1 geneABCG2 geneAdultAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAmyloid beta-ProteinAnimal ModelAnimalsBehavioralBindingBloodBlood - brain barrier anatomyBlood VesselsBody WeightBrainC57BL/6 MouseCell CommunicationCell physiologyCellsCellular Metabolic ProcessCerebrumCharacteristicsChronicCognitive deficitsConsumptionDementiaDepositionDevelopmentDiabetes MellitusDietElderlyEndothelial CellsEnergy MetabolismEpidemicFunctional disorderGlucoseGlucose TransporterGoalsHigh Fat DietHumanHypoxiaImmune responseImpaired cognitionInflammationInflammatoryInflammatory ResponseInsulin ResistanceIntravenousLate Onset Alzheimer DiseaseLeadLesionLinkLipopolysaccharidesMeasuresMetabolic syndromeMicroRNAsMicrogliaModelingMolecularMusNerve DegenerationNeurofibrillary TanglesNeuronsNon-Insulin-Dependent Diabetes MellitusObesityP-GlycoproteinPathogenesisPathologicPathologic ProcessesPathologyPathway AnalysisPatientsPeripheralPermeabilityPhysiological ProcessesPreventivePreventive measureProductionProteinsRNAReportingResearchResearch Project GrantsRiskRisk FactorsRodentRoleSLC2A1 geneSenile PlaquesSignal PathwayTestingTherapeuticTight Junctionsamyloid pathologybrain parenchymacell typecirculating microRNAcognitive functioncytokinediabeticdiabetic ratexosomeextracellular vesiclesglucose metabolismglucose uptakehyperphosphorylated tauhypoperfusionimmunoregulationimpaired glucose toleranceimprovedinsulin sensitivitymembermicrovesiclesmouse modelnervous system disorderneurofibrillary tangle formationneuroinflammationoccludinpreventprotein profilingtau Proteinstrenduptake
项目摘要
Project summary/Abstract
Amyloid plaques composed of deposits of abnormally aggregated amyloid β-protein and neurofibrillary tangles
(NFTs) consisting of abnormal aggregates of hyperphosphorylated tau protein in the brain are two main
pathological changes in patients with Alzheimer's disease (AD). Amyloid plaques and NFTs are accompanied
with chronic inflammation characterized by activated microglia and increased cytokines. The causes for the
vast majority of AD cases are unknown and satisfactory therapeutic and preventive measures for AD are
unavailable. Therefore, an urgent need exists to identify the molecular mechanisms that increase the risk for
the vast majority of AD cases and for development of preventive and therapeutic measures. Over 30% of
adults are currently classified as obese in the US and obesity is considered to be responsible for up to 70-90%
of type 2 diabetes mellitus (T2DM) cases. Consumption of high fat diets (HFD) is strongly associated with
obesity and T2DM. Obesity and T2DM are linked to decreases in cognitive functions in older adults and strong
risk factors of AD. Furthermore, AD patients show decreases in glucose uptake and insulin sensitivity in the
brain and have increased risk for developing T2DM. Additionally, obesity and T2DM are main vascular risk
factors and produce a number of macro- and micro-vascular complications including blood-brain barrier (BBB)
dysfunction and inflammation. According to the vascular hypothesis of AD, vascular risk factors including
diabetes, obesity and systemic inflammation induce hypoperfusion, hypoxia and BBB dysfunction, which cause
reduced Aβ clearance across the BBB, accumulation of brain Aβ, and NFT formation, leading to
neurodegeneration and, ultimately, AD dementia. We hypothesize that blood extracellular vesicles (EVs)
associated with obesity and T2DM have the characteristics of RNA and/or protein profiles that induce the BBB
dysfunction, brain glucose hypometabolism and neuroinflammation in the brain, leading to an increased risk
and accelerated progression of AD. RNAs and proteins abundantly found in EVs have important roles in cell-
to-cell communication and are involved in immune regulation, inflammatory responses, cell metabolism,
metabolic syndrome and neurological disorders. In order to test the hypothesis, we will isolate blood EVs from
HFD- and normal chow diet (NCD)-fed mice, intravenously infuse the EVs into AD model mice and determine
body weight, glucose metabolism, BBB changes, AD-like and inflammatory pathology and behavioral functions
(Aim 1). We will determine protein and RNA profiles of blood EVs from AD model, HFD- and NCD-fed mice
and perform their signaling pathway analysis (Aim 2). The immediate goal of this study is to determine the role
of blood EVs produced by chronic consumption of HFD in the AD pathogenesis. If proven true, this project will
open new research avenues to identify specific molecules (microRNAs and/or proteins) in EVs, which are
responsible for the increased risk of AD in obese and T2DM patients and to ultimately prevent and treat AD.
项目概要/摘要
淀粉样斑块由异常聚集的淀粉样 β 蛋白和神经原纤维缠结组成
(NFT)由大脑中过度磷酸化 tau 蛋白的异常聚集体组成,主要有两种
阿尔茨海默病(AD)患者的病理变化。淀粉样斑块和 NFT 伴随
以小胶质细胞激活和细胞因子增加为特征的慢性炎症。产生的原因
绝大多数AD病例是未知的,并且令人满意的AD治疗和预防措施
不可用。因此,迫切需要确定增加风险的分子机制。
绝大多数 AD 病例以及制定预防和治疗措施。超过30%的
目前在美国,成年人被归类为肥胖,肥胖被认为是造成高达 70-90% 的原因
2 型糖尿病 (T2DM) 病例。高脂肪饮食 (HFD) 的消耗与
肥胖和 T2DM。肥胖和 T2DM 与老年人认知功能下降有关
AD 的危险因素。此外,AD 患者的葡萄糖摄取和胰岛素敏感性降低
脑,并增加患 T2DM 的风险。此外,肥胖和 T2DM 是主要的血管风险
因素并产生许多大血管和微血管并发症,包括血脑屏障(BBB)
功能障碍和炎症。根据AD的血管假说,血管危险因素包括
糖尿病、肥胖和全身炎症会导致低灌注、缺氧和血脑屏障功能障碍,从而导致
跨 BBB 的 Aβ 清除减少、大脑 Aβ 积累和 NFT 形成减少,导致
神经退行性疾病,最终导致 AD 痴呆。我们假设血液细胞外囊泡(EV)
与肥胖和 T2DM 相关的 RNA 和/或蛋白质谱特征可诱导 BBB
功能障碍、脑葡萄糖代谢低下和大脑神经炎症,导致风险增加
并加速 AD 的进展。 EV 中大量存在的 RNA 和蛋白质在细胞-
细胞通讯并参与免疫调节、炎症反应、细胞代谢、
代谢综合征和神经系统疾病。为了检验这一假设,我们将从中分离出血液 EV
HFD 和正常饮食 (NCD) 喂养的小鼠,将 EV 静脉注射到 AD 模型小鼠中并确定
体重、葡萄糖代谢、BBB 变化、AD 样和炎症病理学以及行为功能
(目标 1)。我们将确定 AD 模型、HFD 和 NCD 喂养小鼠的血液 EV 的蛋白质和 RNA 谱
并进行信号通路分析(目标 2)。这项研究的直接目标是确定角色
AD 发病机制中长期食用 HFD 产生的血液 EV。如果证实属实,该项目将
开辟新的研究途径来识别 EV 中的特定分子(microRNA 和/或蛋白质),这些分子是
负责增加肥胖和 T2DM 患者患 AD 的风险,并最终预防和治疗 AD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ken-ichiro Fukuchi其他文献
Ken-ichiro Fukuchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ken-ichiro Fukuchi', 18)}}的其他基金
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10456872 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10314883 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Role of MyD88 signaling in systemic inflammation and Alzheimer disease
MyD88 信号在全身炎症和阿尔茨海默病中的作用
- 批准号:
10611489 - 财政年份:2021
- 资助金额:
$ 19.99万 - 项目类别:
Altering immune tolerance in Alzheimer disease
改变阿尔茨海默病的免疫耐受性
- 批准号:
9979733 - 财政年份:2019
- 资助金额:
$ 19.99万 - 项目类别:
Role of diet-induced miR-34a in Alzheimer disease and dementia
饮食诱导的 miR-34a 在阿尔茨海默病和痴呆中的作用
- 批准号:
9225329 - 财政年份:2017
- 资助金额:
$ 19.99万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8511261 - 财政年份:2013
- 资助金额:
$ 19.99万 - 项目类别:
Role of the MyD88-independent pathway in Alzheimers disease
MyD88 独立通路在阿尔茨海默病中的作用
- 批准号:
8676620 - 财政年份:2013
- 资助金额:
$ 19.99万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
7963696 - 财政年份:2010
- 资助金额:
$ 19.99万 - 项目类别:
Catalytic and non-catalytic Ig gene delivery for Alzheimer's disease
阿尔茨海默病的催化和非催化 Ig 基因递送
- 批准号:
8081811 - 财政年份:2010
- 资助金额:
$ 19.99万 - 项目类别:
Innate immunity in Alzheimer's disease: Role of toll-like receptor signaling
阿尔茨海默氏病的先天免疫:Toll 样受体信号传导的作用
- 批准号:
7904117 - 财政年份:2009
- 资助金额:
$ 19.99万 - 项目类别:














{{item.name}}会员




